ジーエヌアイグループの株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2020/11/02 | 1,826 | 1,955 | 1,778 | 1,908 | +108 | +6% | 3,807,600 |
2020/10/30 | 1,906 | 1,918 | 1,781 | 1,800 | -93 | -4.9% | 2,770,000 |
2020/10/29 | 1,913 | 1,933 | 1,810 | 1,893 | -60 | -3.1% | 4,074,900 |
2020/10/28 | 2,028 | 2,090 | 1,901 | 1,953 | -85 | -4.2% | 5,280,600 |
2020/10/27 | 1,900 | 2,077 | 1,881 | 2,038 | +59 | +3% | 12,997,700 |
2020/10/26 | 2,300 | 2,331 | 1,951 | 1,979 | -129 | -6.1% | 11,896,500 |
2020/10/23 | 2,094 | 2,174 | 2,015 | 2,108 | +48 | +2.3% | 8,393,100 |
2020/10/22 | 2,336 | 2,361 | 2,034 | 2,060 | -226 | -9.9% | 10,788,400 |
2020/10/21 | 2,342 | 2,462 | 2,209 | 2,286 | -204 | -8.2% | 17,990,400 |
2020/10/20 | 2,780 | 2,811 | 2,490 | 2,490 | -700 | -21.9% | 9,429,100 |
2020/10/19 | 3,190 | 3,190 | 3,190 | 3,190 | -700 | -18% | 40,500 |
2020/10/16 | 3,725 | 3,965 | 3,715 | 3,890 | +140 | +3.7% | 1,092,600 |
2020/10/15 | 3,845 | 3,850 | 3,670 | 3,750 | -80 | -2.1% | 611,100 |
2020/10/14 | 3,740 | 3,875 | 3,720 | 3,830 | +115 | +3.1% | 463,200 |
2020/10/13 | 3,860 | 3,865 | 3,670 | 3,715 | -150 | -3.9% | 806,200 |
2020/10/12 | 3,985 | 4,020 | 3,840 | 3,865 | -80 | -2% | 660,700 |
2020/10/09 | 3,755 | 3,980 | 3,755 | 3,945 | +160 | +4.2% | 821,300 |
2020/10/08 | 3,855 | 3,930 | 3,735 | 3,785 | -75 | -1.9% | 785,800 |
2020/10/07 | 3,840 | 3,935 | 3,755 | 3,860 | -20 | -0.5% | 590,400 |
2020/10/06 | 4,060 | 4,070 | 3,820 | 3,880 | -50 | -1.3% | 1,006,300 |
2020/10/05 | 3,825 | 4,020 | 3,775 | 3,930 | +270 | +7.4% | 1,330,900 |
2020/10/02 | 3,785 | 3,900 | 3,625 | 3,660 | - | - | 1,535,400 |
2020/10/01 | 0 | 0 | 0 | 0 | - | - | 0 |
2020/09/30 | 3,595 | 3,930 | 3,475 | 3,740 | +510 | +15.8% | 2,945,000 |
2020/09/29 | 3,030 | 3,245 | 2,936 | 3,230 | +130 | +4.2% | 1,202,100 |
2020/09/28 | 3,305 | 3,345 | 2,962 | 3,100 | -285 | -8.4% | 1,909,200 |
2020/09/25 | 3,515 | 3,530 | 3,230 | 3,385 | -105 | -3% | 1,182,800 |
2020/09/24 | 3,540 | 3,610 | 3,405 | 3,490 | -55 | -1.6% | 1,067,600 |
2020/09/23 | 3,425 | 3,585 | 3,405 | 3,545 | +145 | +4.3% | 903,700 |
2020/09/18 | 3,360 | 3,430 | 3,260 | 3,400 | +60 | +1.8% | 954,200 |
2020/09/17 | 3,285 | 3,360 | 3,240 | 3,340 | +25 | +0.8% | 725,200 |
2020/09/16 | 3,165 | 3,340 | 3,150 | 3,315 | +150 | +4.7% | 1,006,500 |
2020/09/15 | 3,120 | 3,180 | 3,020 | 3,165 | +55 | +1.8% | 884,800 |
2020/09/14 | 3,000 | 3,165 | 2,995 | 3,110 | +135 | +4.5% | 1,190,100 |
2020/09/11 | 2,892 | 3,010 | 2,811 | 2,975 | +127 | +4.5% | 1,723,500 |
2020/09/10 | 3,000 | 3,015 | 2,825 | 2,848 | -152 | -5.1% | 2,328,900 |
2020/09/09 | 2,872 | 3,020 | 2,870 | 3,000 | +98 | +3.4% | 2,123,100 |
2020/09/08 | 2,816 | 2,918 | 2,785 | 2,902 | +91 | +3.2% | 1,460,600 |
2020/09/07 | 2,759 | 2,956 | 2,754 | 2,811 | +58 | +2.1% | 2,845,600 |
2020/09/04 | 2,677 | 2,765 | 2,661 | 2,753 | +26 | +1% | 1,535,600 |
2020/09/03 | 2,650 | 2,745 | 2,617 | 2,727 | +38 | +1.4% | 1,636,800 |
2020/09/02 | 2,751 | 2,811 | 2,635 | 2,689 | -122 | -4.3% | 2,979,700 |
2020/09/01 | 2,514 | 2,828 | 2,510 | 2,811 | +311 | +12.4% | 4,226,100 |
2020/08/31 | 2,454 | 2,516 | 2,411 | 2,500 | +145 | +6.2% | 1,575,500 |
2020/08/28 | 2,490 | 2,537 | 2,292 | 2,355 | -114 | -4.6% | 3,129,300 |
2020/08/27 | 2,509 | 2,610 | 2,448 | 2,469 | -41 | -1.6% | 3,028,900 |
2020/08/26 | 2,470 | 2,560 | 2,415 | 2,510 | +22 | +0.9% | 5,071,600 |
2020/08/25 | 2,586 | 2,689 | 2,462 | 2,488 | -132 | -5% | 9,188,000 |
2020/08/24 | 2,214 | 2,654 | 2,205 | 2,620 | +453 | +20.9% | 9,197,300 |
2020/08/21 | 2,123 | 2,242 | 2,068 | 2,167 | +42 | +2% | 6,838,700 |
1101~
1150
件表示中 / 3692件
類似銘柄と比較する
現在ご覧いただいている「ジーエヌアイ」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
ジーエヌアイ | 241,500円 | +21.7% | +999.9% | 0.00% | 10.06倍 | 3.33倍 |
|
中国の特発性肺線維症で高シェア、肺線維症後続薬進出。米国で人工骨も。米中に研究開発機能 |
東和薬品 | 263,700円 | +15.0% | -7.3% | 2.65% | 8.65倍 | 0.82倍 |
|
後発医薬品メーカーで国内2強の一角。循環器系に強い。直販軸に発展も卸との取引を拡大中 |
ゼリア新薬 | 234,300円 | +14.2% | +41.0% | 1.96% | 11.48倍 | 1.17倍 |
|
製薬中堅。医療用は消化器系中心。滋養強壮剤「ヘパリーゼ」も柱。スイス企業買収で海外展開 |
持田薬 | 309,000円 | +3.0% | +27.5% | 2.59% | 19.56倍 | 0.85倍 |
|
医薬中堅。高脂血症薬、降圧薬など循環器系得意。婦人科系にも強み。消化器系育成。化粧品も |
杏林製薬 | 148,600円 | +8.8% | +99.9% | 3.50% | 9.49倍 | 0.66倍 |
|
医薬中堅。柱のぜんそく薬、呼吸器アレルギー薬は下期に比重。消化器領域育成。後発品も |
市場注目の銘柄
チャート関連のコラム